亚太地区主动脉瓣置换装置市场预测至 2030 年 – 区域分析 – 按产品(无缝线瓣膜和机械瓣膜)、手术(微创手术和开放手术)和最终用户(医院和诊所、门诊手术中心、和别的)。

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 87    |    Report Code: BMIRE00029413    |    Category: Life Sciences

Asia Pacific Aortic Valve Replacement Devices Market

亚太地区主动脉瓣置换装置市场预计将从2022年的13.2315亿美元增长到2030年的34.8938亿美元。预计2022年至2030年复合年增长率为12.9%。

主动脉瓣置换装置的进步推动亚太地区主动脉瓣置换装置市场

微创手术技术(MIS)的发展,例如经导管主动脉瓣置换术(TAVR),使主动脉瓣狭窄(AS)的治疗现代化。经导管主动脉瓣置换术比传统的心脏直视手术侵入性更小,使得不适合手术的高危患者能够接受治疗。此外,材料和设计的发展导致了更坚固和生物相容性主动脉瓣置换术的开发,这改善了患者的治疗效果并降低了并发症的风险。

主动脉瓣领域参与者的一些技术进步替换设备如下:

•   2023 年 1 月,雅培 (Abbott) 的 Navitor 经导管主动脉瓣植入 (TAVI) 系统获得 FDA 批准,用于治疗心脏直视手术高风险的严重主动脉瓣狭窄患者。 Navitor 是该公司广泛的经导管结构性心脏产品组合的最新成员,为医生和患者提供针对一系列严重心脏病的微创治疗选择。

•   2021 年 9 月,雅培的 Epic Plus 和 Epic Plus Supra 支架组织瓣膜获得 FDA 批准,以改善主动脉瓣或二尖瓣疾病患者的治疗选择。通过这款新设备,雅培扩展了其 Epic 手术瓣膜平台。

•   2021 年 8 月,第一个印度制造的 3D 打印心脏瓣膜在钦奈开发出来。新的心脏瓣膜是使用3D打印机开发的,可以克服人造心脏瓣膜的相关问题。因此,技术进步正在主动脉瓣置换设备市场创造利润丰厚的机会。

亚太地区主动脉瓣置换设备市场概览

亚太地区主动脉瓣更换设备市场分为中国、日本、印度、澳大利亚、韩国和亚太其他地区。该地区在全球主动脉瓣置换装置市场中占有重要份额。由于老年人口增加、心血管疾病增加和创新产品可用性等因素,预计亚太地区市场在预测期内将出现显着增长。

亚太主动脉瓣置换设备市场到 2030 年的收入和预测(百万美元)

亚太地区主动脉瓣置换设备市场细分

 

亚太地区主动脉瓣置换装置市场按产品、手术、最终用户和国家/地区进行细分。

根据产品,亚太地区主动脉瓣置换装置市场分为无缝线瓣膜和机械瓣膜。 2022年,无缝线瓣膜将在亚太区主动脉瓣置换装置市场中占据较大份额。

根据手术,亚太区主动脉瓣置换装置市场分为微创手术和开放手术。到2022年,微创手术细分市场将在亚太地区主动脉瓣置换设备市场中占据更大份额。

根据最终用户,亚太地区主动脉瓣置换设备市场分为医院和医院。诊所、门诊手术中心等。医院和医院2022年,诊所细分市场占据亚太地区主动脉瓣置换设备市场份额最大。

按国家/地区划分,亚太地区主动脉瓣置换设备市场分为中国、日本、印度、澳大利亚、韩国、以及亚太地区其他地区。到 2022 年,中国将主导亚太区主动脉瓣置换设备市场。

雅培 (Abbott Laboratories)、Artivion Inc、波士顿科学公司 (Boston Scientific Corp)、Edwards Lifesciences Corp、LivaNova Plc、美敦力 (Medtronic Plc) 和启明医疗科技杭州有限公司 (Venus MedTech HangZhou Inc) 等公司均在其中。亚太地区主动脉瓣置换设备市场的领先公司。



Asia Pacific Aortic Valve Replacement Devices Strategic Insights

Strategic insights for Asia Pacific Aortic Valve Replacement Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-aortic-valve-replacement-devices-market-strategic-framework.webp
Get more information on this report

Asia Pacific Aortic Valve Replacement Devices Report Scope

Report Attribute Details
Market size in 2022 US$ 1,323.15 Million
Market Size by 2030 US$ 3,489.38 Million
Global CAGR (2022 - 2030) 12.9%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 产品
  • 无缝线瓣膜和机械瓣膜
By 手术
  • 微创手术和开放手术
By 最终用户
  • 医院和诊所
  • 门诊手术中心
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Abbott Laboratories
  • Artivion Inc
  • Boston Scientific Corp
  • Edwards Lifesciences Corp
  • LivaNova Plc
  • Medtronic Plc
  • Venus MedTech HangZhou Inc
  • Get more information on this report

    Asia Pacific Aortic Valve Replacement Devices Regional Insights

    The regional scope of Asia Pacific Aortic Valve Replacement Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-aortic-valve-replacement-devices-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Aortic Valve Replacement Devices Market

    1. Abbott Laboratories
    2. Artivion Inc
    3. Boston Scientific Corp
    4. Edwards Lifesciences Corp
    5. LivaNova Plc
    6. Medtronic Plc
    7. Venus MedTech HangZhou Inc
    Frequently Asked Questions
    How big is the Asia Pacific Aortic Valve Replacement Devices Market?

    The Asia Pacific Aortic Valve Replacement Devices Market is valued at US$ 1,323.15 Million in 2022, it is projected to reach US$ 3,489.38 Million by 2030.

    What is the CAGR for Asia Pacific Aortic Valve Replacement Devices Market by (2022 - 2030)?

    As per our report Asia Pacific Aortic Valve Replacement Devices Market, the market size is valued at US$ 1,323.15 Million in 2022, projecting it to reach US$ 3,489.38 Million by 2030. This translates to a CAGR of approximately 12.9% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Aortic Valve Replacement Devices Market report typically cover these key segments-

  • 产品 (无缝线瓣膜和机械瓣膜)
  • 手术 (微创手术和开放手术)
  • 最终用户 (医院和诊所, 门诊手术中心)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Aortic Valve Replacement Devices Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Aortic Valve Replacement Devices Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Asia Pacific Aortic Valve Replacement Devices Market?

    The Asia Pacific Aortic Valve Replacement Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott Laboratories
  • Artivion Inc
  • Boston Scientific Corp
  • Edwards Lifesciences Corp
  • LivaNova Plc
  • Medtronic Plc
  • Venus MedTech HangZhou Inc
  • Who should buy this report?

    The Asia Pacific Aortic Valve Replacement Devices Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Aortic Valve Replacement Devices Market value chain can benefit from the information contained in a comprehensive market report.